sur Rentschler Biopharma SE
Rentschler Biopharma Honored with Business Medal
Rentschler Biopharma SE, a key player in the biopharmaceutical contract development and manufacturing sector, has been awarded the Business Medal of the State of Baden-Wuerttemberg. This recognition was presented on November 5, 2026, by Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labor and Tourism, highlighting the company's significant entrepreneurial achievements and impact on the regional economy.
The honor acknowledges Rentschler Biopharma’s historical and ongoing contribution to both the local and global biopharmaceutical landscape. Dr. Torsten Woehr, CEO of the company, celebrated the award as a testament to the expertise and dedication of the company's workforce.
Rentschler Biopharma, with longstanding roots in Laupheim, has grown into a global leader, supporting various pharmaceutical initiatives. Their latest investment in a buffer media station underscores their commitment to infrastructure and innovation. The completion of this facility is expected by late 2027, further cementing their role in the region's economic future.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Rentschler Biopharma SE